PROMIS NEUROSCIENCES, INC.
Ownership & governance
Executives 5Directors 7Avg age 65Avg tenure 7.6y
NW
Neil Warma
Chief Executive Officer
Age 63Since 2023-12-29Profile →
+11
Executives5
NW
Neil Warma→
Chief Executive Officer
Age 63Since 2023-12-29
NC
Neil Cashman→
Chief Tech/Sci/R&D Officer
Age 74Since 2004-05-30
DG
Daniel Geffken→
Director of Finance/CFO
Age 69Since 2017-03-21
LA
Larry Altstiel→
Chief Tech/Sci/R&D Officer
Age 76Since 2022-04-18
CP
Carie Pierce→
Investor Relations Contact
—Since 2026-02-28
Board of directors7
NC
Neil Cashman→
Chairman
Age 74Since 2012-10-02
WW
William Wyman→
Chairman
Age 88Since 2014-06-11
EW
Eugene Williams→
Chairman
Age 66Since 2015-06-30
NW
Neil Warma→
Director/Board Member
Age 63Since 2021-05-12
JM
Josh Mandel-Brehm→
Director/Board Member
Age 43Since 2021-08-31
MS
Maggie Shafmaster→
Director/Board Member
Age 67Since 2021-09-21
SA
Slanix Alex→
Director/Board Member
Age 36Since 2025-10-21
Shareholders5
| Name | Stake | Shares |
|---|---|---|
| Janus Henderson Investors US LLC | 14.42 % | 1,292,757 |
| Deep Track Capital LP | 9.319 % | 835,655 |
| Ally Bridge Group HK Ltd | 8.296 % | 743,979 |
| Wellington Management Co. LLP (Wellington Breakout) | 7.765 % | 696,378 |
| Wellington Management Co. LLP | 7.765 % | 696,378 |
Catalog · 2026-07-09
Registry officers12
| Name | Role | Since | Shares |
|---|---|---|---|
| Daniel Geffken | Director of Finance/CFO | 2017-03-21 | - |
| Eugene Williams | Chairman | 2015-06-30 | - |
| Larry Altstiel | Chief Tech/Sci/R&D Officer | 2022-04-18 | - |
| Neil Cashman | Chairman | 2012-10-02 | - |
| Neil Cashman | Chief Tech/Sci/R&D Officer | 2004-05-30 | - |
| Neil Warma | Chief Executive Officer | 2023-12-29 | - |
| William Wyman | Chairman | 2014-06-11 | - |
| Josh Mandel-Brehm | Director/Board Member | 2021-08-31 | - |
Registry · as of 2026-07-09
Institutional (13F)
Loading Form 13F holders…
Fund membership
Loading fund baskets…
Street consensus
Consensus strong buyMean target 42.52Range 17.97–97.72Analysts 7
17.97Mean 42.5297.72
- Strong buy 2
- Buy 6
Broker actions16
| Firm | Action | To | Target | Date |
|---|---|---|---|---|
| Guggenheim | Maintained | Buy | 100 | 2026-08-14 |
| Guggenheim | Maintained | Buy | 69 | 2026-07-29 |
| Chardan Capital | Maintained | Buy | 33 | 2026-07-28 |
| Chardan Capital | Initiated | Buy | 20 | 2026-07-27 |
| Roth Capital | Initiated | Buy | 19 | 2026-07-08 |
| Cantor Fitzgerald | Initiated | Overweight | — | 2026-06-30 |
| HC Wainwright & Co. | Reiterated | Buy | 18 | 2026-06-24 |
| HC Wainwright & Co. | Reiterated | Buy | 18 | 2026-06-08 |
| Guggenheim | Maintained | Buy | 35 | 2026-02-06 |
| HC Wainwright & Co. | Maintained | Buy | 18 | 2025-12-01 |
| HC Wainwright & Co. | Reiterated | Buy | 4 | 2025-11-21 |
| Guggenheim | Maintained | Buy | 5 | 2025-11-18 |
Firm rows and rating mix from Yahoo Finance; mean target is Yahoo’s aggregate until OpenFilings derives consensus from broker rows.